Premarket Decliner
PASG Passage Bio11.67-0.01-0.1%
Premarket:8.01-3.66 (-31.4%)
Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates
Globe NewswireMon, 20-Apr 7:00 AM
